Study: Cipro, Related Antibiotics Raise MRSA Risk in LTC Settings

Researchers in France have found that long-term care residents who take fluoroquinolone antibiotics such as Cipro are at an increased risk of developing methicillin-resistant Staphylococcus aureus, or MRSA.

During the study, the researchers tracked roughly 450 residents who were not colonized with MRSA when they were admitted. Seventy-five members of this group developed MRSA and the researchers were able to identify fluoroquinolone use as being associated with its development. They also found that more than 93 percent of the MRSA strains were resistant to fluoroquinolones.

To learn more, click here.